Eli Lilly and Company (LLY) Description, Stock price, News & Info.

#ThinkSabio Latest News

Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor